Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQQ9H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,795
Award facts
- Contract value 100% obligated
- $14,795.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,795.11 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on November 26, 2025, with completion scheduled for November 28, 2025. The award was issued as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its Corporate Office location. This contract represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The delivery order supports DLA's medical supply chain operations, which serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Zepbound is a GLP-1 receptor agonist medication used for weight management in military and veteran healthcare settings. This award reflects AmerisourceBergen Drug Corp's established capability as a primary pharmaceutical vendor for federal medical procurement and its role in the broader Pharmaceutical Prime Vendor Global Program, which DLA has structured to leverage multiple regional contractors for comprehensive global pharmaceutical support to military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FQQ9H?
SPE2DR26FQQ9H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FQQ9H worth?
The government has obligated $14,795 on SPE2DR26FQQ9H.
Is contract SPE2DR26FQQ9H an order under another contract?
Yes. SPE2DR26FQQ9H is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ9H competed?
The extent of competition for SPE2DR26FQQ9H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award